Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
February 5, 2009
Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis
Mohit Neema, Ashish Arora, Brian C Healy, et al.
Archives of Neurology
|
July 15, 2009
Smoking and disease progression in multiple sclerosis
Brian C Healy, Eman N Ali, Charles R G Guttmann, et al.
Muscle & Nerve
|
February 22, 2018
Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis
Radhika Raheja, Keren Regev, Brian C Healy, et al.
Journal of the Neurological Sciences
|
May 12, 2009
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study
S A Gauthier, B I Glanz, M Mandel, et al.
Journal of Neurology
|
August 2, 2023
Multiple sclerosis lesions that impair memory map to a connected memory circuit
Isaiah Kletenik, Alexander L Cohen, Bonnie I Glanz, et al.
Journal of the Neurological Sciences
|
January 3, 2012
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study
Jennifer Moodie, Brian C Healy, Guy J Buckle, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis
James M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Neuroreport
|
August 8, 2014
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2
Rohit Bakshi, Mohit Neema, Shahamat Tauhid, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 4, 2018
Identification of MS-specific serum miRNAs in an international multicenter study
Keren Regev, Brian C Healy, Anu Paul, et al.
Multiple Sclerosis and Related Disorders
|
August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes
Kathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
February 5, 2009
Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis
Mohit Neema, Ashish Arora, Brian C Healy, et al.
Archives of Neurology
|
July 15, 2009
Smoking and disease progression in multiple sclerosis
Brian C Healy, Eman N Ali, Charles R G Guttmann, et al.
Muscle & Nerve
|
February 22, 2018
Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis
Radhika Raheja, Keren Regev, Brian C Healy, et al.
Journal of the Neurological Sciences
|
May 12, 2009
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study
S A Gauthier, B I Glanz, M Mandel, et al.
Journal of Neurology
|
August 2, 2023
Multiple sclerosis lesions that impair memory map to a connected memory circuit
Isaiah Kletenik, Alexander L Cohen, Bonnie I Glanz, et al.
Journal of the Neurological Sciences
|
January 3, 2012
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study
Jennifer Moodie, Brian C Healy, Guy J Buckle, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis
James M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Neuroreport
|
August 8, 2014
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2
Rohit Bakshi, Mohit Neema, Shahamat Tauhid, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 4, 2018
Identification of MS-specific serum miRNAs in an international multicenter study
Keren Regev, Brian C Healy, Anu Paul, et al.
Multiple Sclerosis and Related Disorders
|
August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes
Kathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
Page
of 12